V1RG4 activators constitute a chemical class that can activate the V1RG4 receptor, a member of the vomeronasal type 1 receptor family. These chemicals are not specific activators of V1RG4 but engage in modulating the signaling pathways that the V1RG4 receptor is part of. The activation process involves a range of mechanisms, such as increasing the levels of intracellular second messengers, altering the activity of enzymes that form part of the signaling cascade, and binding to G proteins to modulate their activity. The increase in second messengers like cyclic AMP (cAMP) can result from the direct stimulation of enzymes like adenylyl cyclase or from the inhibition of phosphodiesterases, leading to an accumulation of cAMP within the cell. This elevation of cAMP can activate protein kinase A (PKA), which then phosphorylates various target proteins, potentially influencing the signaling pathways of V1RG4.
In addition to cAMP-related mechanisms, some activators work by modifying the levels of intracellular calcium, which is another pivotal second messenger in cellular signaling. This can be achieved through the use of ionophores that increase calcium influx or by inhibiting enzymes like phospholipase C, which plays a critical role in generating inositol trisphosphate (IP3) and diacylglycerol (DAG), both of which are involved in calcium signaling. Other compounds may activate protein kinase C (PKC), which is also a key player in the phosphorylation events within the cell. By targeting different links in the signaling chain, these activators can modulate the receptor's activity. The interplay between these activators and the V1RG4 receptor is complex, as the receptor's response is contingent on a multitude of intracellular interactions and the cellular context. The precise modulation of V1RG4 receptor signaling can have significant implications for the receptor's role in sensory perception within the vomeronasal system.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Stimulates adenylyl cyclase to increase cAMP levels, which can activate PKA and modulate the activity of V1RG4. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, preventing cAMP degradation, which raises its levels and influences V1RG4 signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, potentially phosphorylating target proteins and modulating the G protein signaling cascade of V1RG4. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inhibits Gi proteins, potentially leading to increased cAMP levels and altering V1RG4 signaling pathways. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $39.00 $45.00 $98.00 | 26 | |
Activates G proteins, influencing the signal transduction of V1RG4. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium levels, affecting the signaling pathways of V1RG4. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $120.00 $275.00 $380.00 $670.00 $1400.00 $3000.00 | 12 | |
Mimics acetylcholine, activating GPCRs and affecting V1RG4 downstream signaling. |